ARTICLE | Company News
BioAlliance, Par Pharmaceutical sales and marketing update
September 6, 2010 7:00 AM UTC
Par's Strativa Pharmaceuticals unit launched Oravig miconazole in the U.S. to treat oropharyngeal candidiasis. Par has exclusive rights to market the extended-release bioadhesive antifungal buccal ta...